Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Noppen, M.
Right arrow Articles by Schandevyl, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Noppen, M.
Right arrow Articles by Schandevyl, W.

Chest, Vol 97, 373-376, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma

M Noppen, L Vanmaele, N Impens and W Schandevyl
Department of Pulmonology, Academic Hospital, Vrije University Brussel, Belgium.

We investigated the bronchodilating effect of intravenous MgSO4 in acute severe bronchial asthma. Infusion of MgSO4 caused a significant improvement in FEV1 (0.94 +/- 0.39L to 1.3 +/- 0.44 L) and an improvement in clinical signs and symptoms in ten out of 12 administrations. The bronchodilating effect of MgSO4, however, was significantly less than that of subsequent albuterol inhalation (FEV1 improvement from 1.13 +/- 0.41 L to 1.72 +/- 0.49 L). These findings confirm that intravenous MgSO4 may be used as an adjunct to classic beta 2-agonist therapy in cases of severe acute asthma; its exact place in the treatment of asthma remains to be determined in large-scale studies.


This article has been cited by other articles:


Home page
 ChestHome page
E. Zervas, G. Papatheodorou, K. Psathakis, P. Panagou, N. Georgatou, and S. Loukides
Reduced Intracellular Mg Concentrations in Patients With Acute Asthma
Chest, January 1, 2003; 123(1): 113 - 118.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
M. Noppen
Magnesium Treatment for Asthma : Where Do We Stand?
Chest, August 1, 2002; 122(2): 396 - 398.
[Full Text] [PDF]

Home page
 ChestHome page
R. A. Silverman, H. Osborn, J. Runge, E. J. Gallagher, W. Chiang, J. Feldman, T. Gaeta, K. Freeman, B. Levin, N. Mancherje, et al.
IV Magnesium Sulfate in the Treatment of Acute Severe Asthma* : A Multicenter Randomized Controlled Trial
Chest, August 1, 2002; 122(2): 489 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
K. S. Kakish
Serum Magnesium Levels in Asthmatic Children During and Between Exacerbations
Arch Pediatr Adolesc Med, February 1, 2001; 155(2): 181 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
L. Ciarallo, D. Brousseau, and S. Reinert
Higher-Dose Intravenous Magnesium Therapy for Children With Moderate to Severe Acute Asthma
Arch Pediatr Adolesc Med, October 1, 2000; 154(10): 979 - 983.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
J. A. Everett
Alternatives to Standard Status Asthmaticus Therapy
Journal of Pharmacy Practice, June 1, 1997; 10(3): 186 - 199.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American College of Chest Physicians.